Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape
Join us for the second session in a series of webinars dedicated to promising neuro biomarkers.
Our webinar series about promising neuro biomarkers
In this edition, Dr. Giovanni Bellomo and Dr. Patrick Öckl will discuss how emerging synaptic biomarkers, such as β synuclein, contribute to our understanding of different neuronal pathologies.
The webinar is moderated by Dr. Shreyasee Das from ADx NeuroSciences, a Fujirebio company.
Reserve your seat today
Starts on 2026/03/03 - 10:00 AM EST / 16:00 CET Duration: 1 hourThe speakers
Dr. Giovanni Bellomo
Link Campus University, Perugia, Italy. Focuses on the discovery, validation, and clinical implementation of fluid biomarkers for neurodegenerative diseases, with particular emphasis on Alzheimer’s disease and Parkinson's disease.
Dr. Bellomo's Neuro Biomarker Talk:
Synaptic biomarkers in synucleinopathies and in the clinical continuum of Alzheimer’s disease
Dr. Patrick Öckl
Ulm University Hospital, DZNE, Ulm, Germany. His interest is to uncover pathological mechanisms of neurodegenerative diseases and the discovery, validation, and implementation of biomarkers in cerebrospinal fluid and blood to improve diagnosis, personalized medicine, and drug development.
Dr. Öckl's Neuro Biomarker Talk:
Blood β-synuclein as synaptic biomarker in Alzheimer’s disease
For whom this webinar is intended
This session is open for all but was designed for the following professions engaged in neurodegenerative disease research with a focus on synaptic biomarkers.
- Researchers
- Pharmaceutical professionals
- Biotechnology professionals
- CROs (Contract Research Organizations)
- Technology providers
